Acurx Stock Probability of Future Stock Price Finishing Over 2.92

ACXP
 Stock
  

USD 2.92  0.01  0.34%   

Acurx Pharmaceuticals' future price is the expected price of Acurx Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Acurx Pharmaceuticals performance during a given time horizon utilizing its historical volatility.
  
Acurx Pharmaceuticals' implied volatility is one of the determining factors in the pricing options written on Acurx Pharmaceuticals. Implied volatility approximates the future value of Acurx Pharmaceuticals based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Acurx Pharmaceuticals over a specific time period. For example, 2022-12-16 PUT at $5.0 is a PUT option contract on Acurx Pharmaceuticals' common stock with a strick price of 5.0 expiring on 2022-12-16. The contract was not traded in recent days and, as of today, has 19 days remaining before the expiration. The option is currently trading at a bid price of $0.8, and an ask price of $3.5. The implied volatility as of the 27th of November is 180.6664. View All Acurx options

Closest to current price Acurx long PUT Option Payoff at Expiration

Please continue to Acurx Pharmaceuticals Backtesting, Acurx Pharmaceuticals Valuation, Acurx Pharmaceuticals Correlation, Acurx Pharmaceuticals Hype Analysis, Acurx Pharmaceuticals Volatility, Acurx Pharmaceuticals History as well as Acurx Pharmaceuticals Performance. Please specify Acurx Pharmaceuticals time horizon, a valid symbol (red box) and a target price (blue box) you would like Acurx Pharmaceuticals odds to be computed.

Acurx Pharmaceuticals Target Price Odds to finish over 2.92

The tendency of Acurx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.92 90 days 2.92 
about 82.2
Based on a normal probability distribution, the odds of Acurx Pharmaceuticals to move above the current price in 90 days from now is about 82.2 (This Acurx Pharmaceuticals probability density function shows the probability of Acurx Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Acurx Pharmaceuticals has a beta of 0.58. This suggests as returns on the market go up, Acurx Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Acurx Pharmaceuticals will be expected to be much smaller as well. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Acurx Pharmaceuticals is significantly underperforming DOW.
   Acurx Pharmaceuticals Price Density   
       Price  

Predictive Modules for Acurx Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acurx Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Acurx Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Acurx Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.152.937.75
Details
Intrinsic
Valuation
LowReal ValueHigh
0.325.149.96
Details
Naive
Forecast
LowNext ValueHigh
0.063.147.96
Details
1 Analysts
Consensus
LowTarget PriceHigh
12.0012.0012.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Acurx Pharmaceuticals. Your research has to be compared to or analyzed against Acurx Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Acurx Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Acurx Pharmaceuticals.

Acurx Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Acurx Pharmaceuticals is not an exception. The market had few large corrections towards the Acurx Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Acurx Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Acurx Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over DOW
-0.29
β
Beta against DOW0.58
σ
Overall volatility
0.39
Ir
Information ratio -0.07

Acurx Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acurx Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acurx Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Acurx Pharmaceuticals generated a negative expected return over the last 90 days
Acurx Pharmaceuticals has high historical volatility and very poor performance
Acurx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (12.56 M).
Acurx Pharmaceuticals currently holds about 9.09 M in cash with (8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8.
Roughly 22.0% of the company shares are held by company insiders

Acurx Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acurx Stock often depends not only on the future outlook of the current and potential Acurx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acurx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out0.26%
Short Percent Of Float0.33%
Float Shares9M
Shares Short Prior Month26.57k
Average Daily Volume Last 10 Day20.39k
Average Daily Volume In Three Month23.11k
Date Short Interest14th of October 2022

Acurx Pharmaceuticals Technical Analysis

Acurx Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Acurx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acurx Pharmaceuticals. In general, you should focus on analyzing Acurx Stock price patterns and their correlations with different microeconomic environments and drivers.

Acurx Pharmaceuticals Predictive Forecast Models

Acurx Pharmaceuticals time-series forecasting models is one of many Acurx Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Acurx Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Acurx Pharmaceuticals

Checking the ongoing alerts about Acurx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acurx Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Acurx Pharmaceuticals generated a negative expected return over the last 90 days
Acurx Pharmaceuticals has high historical volatility and very poor performance
Acurx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (12.56 M).
Acurx Pharmaceuticals currently holds about 9.09 M in cash with (8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8.
Roughly 22.0% of the company shares are held by company insiders
Please continue to Acurx Pharmaceuticals Backtesting, Acurx Pharmaceuticals Valuation, Acurx Pharmaceuticals Correlation, Acurx Pharmaceuticals Hype Analysis, Acurx Pharmaceuticals Volatility, Acurx Pharmaceuticals History as well as Acurx Pharmaceuticals Performance. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for analysis

When running Acurx Pharmaceuticals price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Acurx Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acurx Pharmaceuticals. If investors know Acurx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acurx Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
35.6 M
Return On Assets
(0.55) 
Return On Equity
(0.95) 
The market value of Acurx Pharmaceuticals is measured differently than its book value, which is the value of Acurx that is recorded on the company's balance sheet. Investors also form their own opinion of Acurx Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acurx Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acurx Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acurx Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acurx Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Acurx Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acurx Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.